Skip to main content
Conan G. Kinsey
( out of 39 reviews )

Conan G. Kinsey, MD, PhD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Clinic 3A, Gastrointestinal
Salt Lake City
  • Board Certification

    American Board of Internal Medicine

    Patient Rating

    5.0 /5
    ( out of 39 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    April 26, 2024

    Fantastic Doctor! Very caring and understanding.

    April 19, 2024

    Dr Kinsey is a wonderful doctor. Always caring, takes the time to listen to me and answers all of my questions in a way for me to understand.

    April 01, 2024

    Great human being, easy to understand the complex world of cancer and a lot empathy from his side

    March 29, 2024

    Dr Kinsey doesn't waste time. He gets right to the point, explains everything, and works with me to get what I need/want

    March 16, 2024

    Great knowledge, attitude & positivity. Exactly who you want on your team to help you through a tough situation.

    March 08, 2024

    Dr Kinsey is a wonderful doctor. Always makes me feel like he cares about me and what I am going through. He listens to me about my concerns and answers all of my questions in a way that I understand. I am very thankful to have him as my oncologist and I would highly recommend him.

    February 24, 2024

    always look forward to meeting with DR Kinsey

    February 24, 2024

    Dr Kinsey always takes the time to make sure I understand and will explain in different ways if needed to make sure I understand and he does it in a caring way.

    February 22, 2024

    Dr. Kinsey is very thorough and truly cares about his patients. I have been completely satisfied with all aspects of his care and the coordination with his whole team. Thank you!

  • Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Oncological Sciences -Adjunct
    Academic Divisions Oncology
    Board Certification
    American Board of Internal Medicine

    Education history

    Postdoctoral Fellowship Hematology/Oncology - Huntsman Cancer Institute Postdoctoral Fellow
    Hematology/Oncology - Huntsman Cancer Institute Fellow
    Residency Internal Medicine - University of Utah School of Medicine Resident
    Genetics and Medicine - University of Rochester School of Medicine and Dentistry M.D., Ph.D.
    Undergraduate Cell Biology/Biochemistry - Bucknell University B.S.

    Selected Publications

    Journal Article

    1. Vaishnavi A, Kinsey CG, McMahon M (2023). Preclinical Modeling of Pathway-Targeted Therapy of Human Lung Cancer in the Mouse. Cold Spring Harb Perspect Med. (Read full article)
    2. Vaishnavi A, Juan J, Jacob M, Stehn C, Gardner EE, Scherzer MT, Schuman S, Van Veen JE, Murphy B, Hackett CS, Dupuy AJ, Chmura SA, van der Weyden L, Newberg JY, Liu A, Mann K, Rust AG, Weiss WA, Kinsey CG, Adams DJ, Grossmann A, Mann MB, McMahon M (2021). Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis. Cancer Res, 82(22), 4261-4273. (Read full article)
    3. Foth M, Garrido-Laguna I, Kinsey CG (2021). Therapeutic Targeting of Autophagy in Pancreatic Cancer. Surg Oncol Clin N Am, 30(4), 709-718. (Read full article)
    4. Truong A, Yoo JH, Scherzer MT, Sanchez JMS, Dale KJ, Kinsey CG, Richards JR, Shin D, Ghazi PC, Onken MD, Blumer KJ, Odelberg SJ, McMahon M (2020). Chloroquine Sensitizes GNAQ/11-mutated Melanoma to MEK1/2 Inhibition. Clin Cancer Res, 26(23), 6374-6386. (Read full article)
    5. Vaishnavi A, Scherzer MT, Kinsey CG, Parkman GL, Truong A, Ghazi P, Schuman S, Battistone B, Garrido-Laguna I, McMahon M (2019). Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer. Cell Rep, 32(5), 107994. (Read full article)
    6. Kinsey C, Balakrishnan V, ODell MR, Huang JL, Newman L, Whitney-Miller CL, Hezel AF, Land H (2014). Plac8 links oncogenic mutations to regulation of autophagy and is critical to pancreatic cancer progression. Cell Rep, 7(4), 1143-55. (Read full article)
    7. McMurray HR, Sampson ER, Compitello G, Kinsey C, Newman L, Smith B, Chen SR, Klebanov L, Salzman P, Yakovlev A, Land H (2008). Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype. Nature, 453(7198), 1112-6. (Read full article)
    8. Kinsey CG, Bussolati G, Bosco M, Kimura T, Pizzorno MC, Chernin MI, Cassoni P, Novak JF (2007). Constitutive and ligand-induced nuclear localization of oxytocin receptor. J Cell Mol Med, 11(1), 96-110. (Read full article)
    9. Takahashi M, Chernin MI, Yamamoto O, Tonzetich J, Kinsey CG, Novak JF (2002). Transformation of MC3T3-E1 cells following stress and transfection with pSV2neo plasmid. Anticancer Res, 22(2A), 585-98. (Read full article)


    1. Gajiwala S, Torgeson A, Garrido-Laguna I, Kinsey C, Lloyd S (2018). Combination immunotherapy and radiation therapy strategies for pancreatic cancer-targeting multiple steps in the cancer immunity cycle. [Review]. J Gastrointest Oncol, 9(6), 1014-1026. (Read full article)

    Book Chapter

    1. Gilcrease GW, Kinsey C, Stenehjem D (2015). Environmental and genetic risk factors in hepatocellular carcinoma. In Torre A, Uscanga L (Eds.), Medicina Individualizada De La Evidencia A La Práctica Clínica (pp. 155-62). Permanyer México.
  • News & Podcasts

    Huntsman Cancer Institute News